rs121908464
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_201525.4(ADGRG1):c.1675C>T(p.Arg559Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R559Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_201525.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRG1 | NM_201525.4 | c.1675C>T | p.Arg559Trp | missense_variant | 13/14 | ENST00000562631.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRG1 | ENST00000562631.7 | c.1675C>T | p.Arg559Trp | missense_variant | 13/14 | 1 | NM_201525.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247534Hom.: 0 AF XY: 0.00000747 AC XY: 1AN XY: 133944
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461174Hom.: 0 Cov.: 34 AF XY: 0.0000138 AC XY: 10AN XY: 726866
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74354
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 27, 2016 | The R565W variant in the GPR56 gene has been reported previously in the homozygous state in multiple children affected with bilateral frontoparietal polymicrogyria (Piao et al., 2004; Piao et al., 2005). Functional studies show that cells transfected with R565W demonstrate a lack of surface expression (Ke et al., 2008; Luo et al., 2014). The R565W variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R565W variant is a non-conservative amino acid substitution, which occurs at a position that is not conserved. Therefore, the R565W variant is a strong candidate for a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 04, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 565 of the ADGRG1 protein (p.Arg565Trp). This variant is present in population databases (rs121908464, gnomAD 0.008%). This missense change has been observed in individuals with bilateral frontoparietal polymicrogyria (PMID: 15044805, 19016831). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5831). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ADGRG1 protein function. Experimental studies have shown that this missense change affects ADGRG1 function (PMID: 21349848, 24949629, 28424266). For these reasons, this variant has been classified as Pathogenic. - |
Bilateral frontoparietal polymicrogyria Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2011 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant p.R565W in ADGRG1 (NM_005682.7) has been previously reported in mutliple affected indviduals (Chiang NY et al).Functional studies have shown a damaging effect (Luo R et al). The variant has been submitted to ClinVar as Pathogenic. The p.R565W variant is observed in 1/34,456 (0.0029%) alleles from individuals of Latino background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.R565W missense variant is predicted to be damaging by both SIFT and PolyPhen2. The nucleotide c.1693 in ADGRG1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at